Vor Biopharma Inc. (VOR) Reports In-Line Q3 EPS

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• Trex (TREX) PT Raised to $60; Truist: 'We expect the stock to move up notably on this result'